Resistance to arsenic- and antimony-based drugs

Bioinorganic Chemistry and Applications

Volumn 1, Issue 2, 2003, Pages 189-198

  Salerno, Milena ^a   Garnier Suillerot, Arlette ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 46549083220     PISSN: 15653633     EISSN: 1687479X     Source Type: Journal    
DOI: 10.1155/S1565363303000153     Document Type: Article

References (56)

1. M. Gottesman, I. Pastan and S. Ambudkar, Curr. Biol. 6, 610 (1996).
2. F. Sharom, J. Membrane Biol. 160, 161 (1997).
3. P. Borst and M. Ouellette, Annu. Rev. Microbiol. 49, 427 (1995).
4. H. Bolhuis, H. vanVeen, B. Poolman, A. Driessen and W. Konings, FEMS Microbiol. Rev. 21, 55 (1997).
5. P. Borst, R. Evers, M. Kool and J. Wijnholds, J. Nat. Cancer Inst. 92, 1295 (2000).
6. C. Higgins , Annu. Rev. Cell Biol. 8, 67 (1992).
7. D. Loe, K. Almquist, R. Deeley and S. Cole, J. Biol. Chem. 271, 675 (1996).
8. I. Leier, G. Jedlitschky, U. Buchholz, S. Cole, R. Deeley and D. Keppler J. Biol. Chem. 269, 27807 (1994).
9. C. Versantvoort, H. Broxterman, T. Bagrij, R. Scheper and P. Twentyman, Br. J. Cancer 72, 82 (1995).
10. J. Renes, E. De Vries, E. Nuenhuis, P. Jansen, and M. Muller, Br. J. Pharmacol. 126, 681 (1999).
11. C. Marbeuf-Gueye, H. Broxterman, F. Dubru, W. Priebe and A. Garnier-Suillerot, Mol. Pharmacol. 53, 141 (1998).
12. M. Salerno and A. Garnier-Suillerot, Eur. J. Pharmacol. 421, 1 (2001).
13. P. Enterline, R. Day and G. Marsh, Occup. Environ. Med. 52, 28 (1995).
14. H. Chiou, W. Huang, C. Su, S. Chang, Y. Hsu and C. Chen, Stroke 28, 1717 (1997).
15. C. Hopenhayn-Rich, M. Biggs and A. Smith, Int. J. Epidemiol. 27, 561 (1998).
16. D. Lewis, J. Southwick, R. Ouellet-Hellstrom, J. Rench and R. Calderon, Environ. Health Perspect. 107,59 (1999).
17. E. Crecelius, Environ. Health Perspect. 19, 147 (1977).
18. T. Smith, E. Crecelius and J. Reading JC Environ. Health Perspect. 19, 89 (1977).
19. H. Yamauch and Y. Yamamura, Ind. Hyg. 17, 79 (1979)..
20. W. Cullen, B. McBride and J. Reglinskli, J. Inorg. Biochem. 21, 179 (1984).
21. W. Cullen, B. McBride, H. Manji, A. Pickett and J. Reglinsky, Appl. Organomet. Chem. 3, 71 (1989).
22. M. Mass, A. Tennant, B. Roop, W. Cullen, M. Styblo, D. Thomas and A. Kigerman, Chem. Res. Toxicol. 14, 355 (2001).
23. M. Wei, H. Wanibuchi, S. Yamamoto, W. Li and H. Fukushima, Carcinogenesis 20, 1873 (1999).
24. N. Scott, K. Hatelid, N. MacKenzie and D. Cater, Chem. Res. Toxicol. 6, 102 (1993)..
25. M. Delnomdedieu, M. Basti, J. Otvos and J. Thomas, Chem.- Biol. Inter. 90, 139 (1994).
26. R. Zakharyan and H. Aposhian, Chem. Res. Toxicol. 12, 1278 (1999).
27. T. Radabaugh and H. Aposhian,. Chem. Res. Toxicol. 13, 26 (2000).
28. D. Rabenstein, Metal complexes of glutathione and their biological significance. In: Glutathione: Chemical, Biochemical and Medicinal Aspects (D. Dolphin, O. Avramomic and R. Poulson eds) pp 147-186. John Wiley & Sons, New York (1998).
29. M. Salerno, M. Petroutsa and A. Garnier-Suillerot, J. Bioenerg. Biomembr. 34, 135 (2002).
30. S. Kala, M. Neely, G. Kala , C. Prater, D. Atwood, J. Rice and M. Liberman, J. Biol. Chem. 275, 33404 (2000).
31. Z. Gregus, A. Gyurasics and I. Csanaky, Toxicol. Sci 56, 18 (2000).
32. H. Aposhian, Pharmacol. Toxicol. 37, 397 (1997).
33. R. Mukhopadhyay, S. Dey, N. Xu, D. Gage, J. Lightbody, M. Ouellette and B. Rosen, Proc. Natl. Acad. Sci. USA 93, 10383 (1996).
34. S. Dey and B. Rosen in: Drug Transport in Antimicrobial and Anticancer Chemotherapy (N. Georgopapadakoi, ed.) pp.103-132, Dekker (1995).
35. B. Rosen, Trends Microbiol. 208, 207 (1999).
36. R. Ashford, P. Desjeux and P. de Raadt, Parasitol. Today 8, 104 (1992).
37. S. Reiner, R. and R. Locksley, Annu. Rev. Immunol. 13, 151 (1995).
38. J. Berman, D. Waddell and B. Hanson, Antimicrob. Agents Chemother. 39, 1243 (1985).
39. W. Roberts, J. Berman and P. Rainey, Antimicrob. Agents Chemother. 39, 1234 (1995).
40. B. Papadopoulou, C. Kundig, A. Singh and M. Ouellette, Drug Resistance Updates 1, 266 (1998).
41. J. Jackson, J. Tally and W. Ellis, Am. J. Trop. Med. Hyg. 43, 464 (1990).
42. M. Ouellette and B. Papadopoulou, Parasitol. Today 9, 150 (1993).
43. P. Shaked-Mishan, N. Ulrich, M. Ephros and D. Zilberstein, J. Biol. Chem. 276, 3971 (2001).
44. D. Legar, S. Cayer, A. Singh, D. Richard, B. Papadopoulou and M. Ouellette, J. Bioenerg. Biomembrane 33, 469 (2001).
45. M. Wintrobe, Clinical Hematology, 3rd edn. Henry Kimpton, London, pp 723, 866, 917 (1951).
46. Z. Shen, G. Chen, J. Ni, X. Li, S. Xion, Q. Qiu, J. Zhu, W. Tang, G. Sun, K. Yang, Y. Chen, Z. Fang, Y. Wang, J. Ma, P. Zhang, T. Zhang, S. Chen and Z. Wang, Blood 9, 3354 (1997).
47. A. Bode and Z. Dong, Drug Resistance Update 3, 21 (2000).
48. S. Cole, K. Sparks, K. Fraser, D. Loe, C. Grant, G. Wilson and R. Deeley, Cancer Res. 54, 5902 (1994).
49. B. Stride, C. Grant, D. Loe, D. Hipfner, S. Cole and R. Deeley, Mol. Pharmacol. 52, 344(1997).
50. L. Vernhet, N. Allain, C. Bardia, J.-P. Anger and O. Fardel, Toxicol. 142, 127 (2000).
51. L. Vernhet, A. Courtois, L. Payen, N. Allain, J.P. Anger, A. Guillouzou and O. Fardel, FEBS Lett. 443, 321 (1999).
52. Z. Chen, Z. Wang, and S. Chen, Pharmacol. Ther. 76, 141 (1997).
53. D. Loe, R. Deeley and S. Cole,(1998). Cancer Res. 58, 5130 (1998).
54. Z. Gregus and A. Gyurasics, Biochem. Pharmacol. 59, 1375 (2000).
55. A. Gyurasics, L. Koszorus, F. Varga and Z. Gregus, Z., Biochem. Pharmacol. 44, 1275 (1992).
56. G. Zaman, J. Lankelma, O., Vantellingen, J. Beijnen, H. Dekker, C. Paulusma, R. Oudeelferink, F. Baas and P. Borst, Proc. Natl. Acad. Sci., USA 92, 7690 (1995)